Skip to content

Drug interactions

Everolimus + Golimumab

Severity: Major

Everolimus and Golimumab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Everolimus is an mTOR inhibitor with immunosuppressive activity, and golimumab blocks TNF-alpha. Together they increase the risk of serious and opportunistic infections.

What this interaction means in plain words

Everolimus and Golimumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Everolimus belongs to Oncology; Golimumab belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Additive immunosuppression via TNF blockade and mTOR inhibition of T-cell proliferation.

What to do

Avoid the combination where an alternative exists. If it is necessary, monitor closely for infection and review the need for both agents regularly.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Everolimus and Golimumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Everolimus with Golimumab?

MediHelp rates the interaction as major. Everolimus and Golimumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Everolimus is an mTOR inhibitor with immunosuppressive activity, and golimumab blocks TNF-alpha. Together they increase the risk of serious and opportunistic infections.

How serious is the interaction between Everolimus and Golimumab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where an alternative exists. If it is necessary, monitor closely for infection and review the need for both agents regularly.

What other medicines interact with Golimumab?

MediHelp also lists interactions of Golimumab with, for example, Bcg vaccine live, Etanercept, Influenza virus vaccine quadrivalent intranasal. The full list is on the Golimumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in